Relation between upregulation of CD40 system and complex stenosis morphology in patients with acute coronary syndrome

Acta Pharmacologica Sinica

Volumn 25, Issue 2, 2004, Pages 251-256

  Yan, Jin Chuan ^a   Wu, Zong Gui ^b   Kong, Xian Tao ^b   Zong, Ren Qian ^b   Zhan, Lin Zen ^b  

^a SOUTHEAST UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

CD40 antigens; CD40 ligand; Coronary disease; Matrix metalloproteinases

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; GELATINASE B; SOLUBLE CD40 LIGAND; STROMELYSIN; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORRELATION ANALYSIS; DISEASE MARKER; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEART MUSCLE ISCHEMIA; HUMAN; MALE; PROTEIN EXPRESSION; STABLE ANGINA PECTORIS; THROMBOCYTE; UNSTABLE ANGINA PECTORIS; UPREGULATION;

AGED; ANGINA PECTORIS; ANGINA, UNSTABLE; ANTIGENS, CD40; BLOOD PLATELETS; CD40 LIGAND; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MYOCARDIAL INFARCTION; UP-REGULATION;

EID: 0442309435     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Phipps RP. Atherosclerosis: the emerging role of inflammmation and the CD40-CD40 ligand system. Proc Natl Acad Sci USA 2000; 97: 6930-2.
2. Michelson AD, Barnard MR, Krueger LA, Frelinger AL 3rd, Furman MI. Evaluation of platelet function by flow cytometry. Methods 2000; 21: 259-70.
3. Kaski JC, Chester MR, Chen L, Katritsis D. Rapid angiographic progression of coronary artery disease in patients with angina pectoris: the role of complex stenosis morphology. Circulation 1995; 92: 2058-65.
4. Kai H, Ikeda H, Yasukawa H, Kai M, Seki Y, Kuwahara F, et al. Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol 1998; 32: 368-72.
5. Inokubo Y, Hanada H, Ishizaka H, Fukushi T, Kamada T, Okumura K. Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome. Am Heart J 2001; 141: 211-7.
6. Yan JC, Wu ZG, Li L, Zhong RQ, Kong XT. The clinical implications of increased expression of CD40L in patients with acute coronary syndromes. Chin Med J 2002; 115: 491-3.
7. Peng DQ, Zhao SP, Li YF, Li J, Zhou HN. Elevated soluble CD40 ligand is related to the endothelial adhesion molecules in patients with acute coronary syndrome. Clin Chim Acta 2002; 319: 19-26.
8. Phipps RP, Koumas L, Leung E, Reddy SY, Blieden T, Kaufman J. The CD40-CD40 ligand system: a potential therapeutic target in atherosclerosis. Curr Opin Investig Drugs 2001; 2: 773-7.
9. Ozmen J, Bobryshev YV, Lord RS. CD40 co-stimulatory molecule expression by dendritic cells in primary atherosclerotic lesions in carotid arteries and in stenotic saphenous vein coronary artery grafts. Cardiovasc Surg 2001; 9: 329-33.
10. Mach F, Schonbeck U, Sukhova GK, Atkinson E, Libby P. Reduction of atherosclerosis in mice by inhibition CD40 sinalling. Nature 1998; 394: 200-3.
11. Wilson RF, Holida MD, White CW. Quantitative angiographic morphology of coronary stenoses leading to myocardial infarction or unstable angina. Circulation 1986; 73: 286-93.
12. Divies MJ. Stability and instability: two faces of coronary atherosclerosis. Circulation 1996; 94: 2013-20.
13. Schroeder AP, Falk E. Vulnerable and dangerous coronary plaques. Atherosclerosis 1995; 118: S141-9.
14. Aukrust P, Muller F, Ueland Thor BS, Berget T, Aaser E, Brunsvig BS, et al. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Circulation 1999; 100: 614-20.